Cary Street Partners Investment Advisory’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,410
Closed -$23.8K 764
2024
Q2
$23.8K Buy
+3,410
New +$25.8K ﹤0.01% 743
2023
Q2
Sell
-750
Closed -$6.08K 1751
2023
Q1
$6.08K Hold
750
﹤0.01% 1278
2022
Q4
$4.71K Buy
+750
New +$5.24K ﹤0.01% 1343

Other funds holding BHC

Cary Street Partners Investment Advisory's BHC Position: Q3 2024 in Review

Cary Street Partners Investment Advisory sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 3,410 shares — an estimated $23.8K sold.

Cary Street Partners Investment Advisory first reported a position in BHC in Q4 2022 and held it in 3 quarters. The position peaked at $23.8K in Q2 2024. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • Cary Street Partners Investment Advisory reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 3,410 Bausch Health shares in Q3 2024, an estimated $23.8K.
  • Cary Street Partners Investment Advisory first reported a position in Bausch Health in Q4 2022 and held it in 3 quarters.
  • Cary Street Partners Investment Advisory's Bausch Health position peaked at $23.8K in Q2 2024.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Cary Street Partners Investment Advisory's 13F filing for Q3 2024, filed 30 Oct 2024.